Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Bryan P. Bednarz

Preclinical Pharmacokinetics and Dosimetry Studies of [124i/131i]-Clr1404 for Treatment of Pediatric Solid Tumors in Murine Xenograft Models

Journal of Nuclear Medicine

English

Technical Note: Characterization of Clinical Linear Accelerator Triggering Latency for Motion Management System Development

English

Related publications

Preclinical Studies of 5-Fluoro-2′-Deoxycytidine and Tetrahydrouridine in Pediatric Brain Tumors

Journal of Neuro-Oncology

English

124I PET-Based 3d-Rd Dosimetry for a Pediatric Thyroid Cancer Patient: Real-Time Treatment Planning and Methodologic Comparison

Journal of Nuclear Medicine

English

P3.13-29 Patient-Derived Xenograft Models(PDX) of Lung Squamous Cell Carcinoma(SCC) for Preclinical Studies

Journal of Thoracic Oncology

English

Preclinical Evaluation of the PARP Inhibitor, Olaparib, in Combination With Cytotoxic Chemotherapy in Pediatric Solid Tumors

Pediatric Blood and Cancer

English

On the Selection of a Tracer for PET Imaging of HER2-Expressing Tumors: Direct Comparison of a 124i-Labeled Affibody Molecule and Trastuzumab in a Murine Xenograft Model

Journal of Nuclear Medicine

English

Establishment and Characterization of Histologically and Molecularly Stable Soft Tissue Sarcoma Xenograft Models for Biological Studies and Preclinical Drug Testing

Molecular Cancer Therapeutics

Cancer Research

Oncology

2019

English

93. A Xenograft Model of Skeletal Muscle for Preclinical Gene Therapy Studies

English

Establishment of a Bioluminescent Canine B-Cell Lymphoma Xenograft Model for Monitoring Tumor Progression and Treatment Response in Preclinical Studies

PLoS ONE

Multidisciplinary

2018

English

Surgical Management in Pediatric Malignant Solid Tumors

Journal of Nihon University Medical Association

2018

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Bryan P. Bednarz

Preclinical Pharmacokinetics and Dosimetry Studies of [124i/131i]-Clr1404 for Treatment of Pediatric Solid Tumors in Murine Xenograft Models

Technical Note: Characterization of Clinical Linear Accelerator Triggering Latency for Motion Management System Development

Related publications

Preclinical Studies of 5-Fluoro-2′-Deoxycytidine and Tetrahydrouridine in Pediatric Brain Tumors

124I PET-Based 3d-Rd Dosimetry for a Pediatric Thyroid Cancer Patient: Real-Time Treatment Planning and Methodologic Comparison

P3.13-29 Patient-Derived Xenograft Models(PDX) of Lung Squamous Cell Carcinoma(SCC) for Preclinical Studies

Preclinical Evaluation of the PARP Inhibitor, Olaparib, in Combination With Cytotoxic Chemotherapy in Pediatric Solid Tumors

On the Selection of a Tracer for PET Imaging of HER2-Expressing Tumors: Direct Comparison of a 124i-Labeled Affibody Molecule and Trastuzumab in a Murine Xenograft Model

Establishment and Characterization of Histologically and Molecularly Stable Soft Tissue Sarcoma Xenograft Models for Biological Studies and Preclinical Drug Testing

93. A Xenograft Model of Skeletal Muscle for Preclinical Gene Therapy Studies

Establishment of a Bioluminescent Canine B-Cell Lymphoma Xenograft Model for Monitoring Tumor Progression and Treatment Response in Preclinical Studies

Surgical Management in Pediatric Malignant Solid Tumors